Related Experiment Videos
Initial treatment of Hemophilus influenzae infections in children
American Family Physician
|August 1, 1983
Insights
Chloramphenicol is crucial for treating severe pediatric infections caused by Haemophilus influenzae, including meningitis. It effectively combats both susceptible and resistant strains, ensuring reliable central nervous system penetration.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Haemophilus influenzae (H. influenzae) causes life-threatening pediatric infections.
- Conditions include meningitis, septic arthritis, cellulitis, and epiglottitis.
Purpose of the Study:
- To highlight the importance of chloramphenicol in initial pediatric infection therapy.
- To emphasize its efficacy against H. influenzae.
Main Methods:
- Clinical guidelines and antimicrobial susceptibility data review.
- Pharmacokinetic properties of chloramphenicol, particularly CNS penetration, were considered.
Main Results:
- Chloramphenicol demonstrates effectiveness against both ampicillin-susceptible and ampicillin-resistant H. influenzae.
- The drug reliably penetrates the central nervous system, crucial for meningitis treatment.
Conclusions:
- Chloramphenicol should be included in initial hospital therapy for suspected H. influenzae pediatric infections.
- Its broad efficacy and CNS penetration make it a vital treatment option.
Abstract:
Life-threatening pediatric infections in which H. influenzae is the potential pathogen include meningitis, septic arthritis, cellulitis and epiglottis. Until the pathogen is identified, chloramphenicol should be part of the initial hospital therapy. This agent is effective against ampicillin-susceptible and ampicillin-resistant H. influenzae strains, and it reliably penetrates the central nervous system.